All Type of News
Basaglar, a Lantus biosimilar, enters the domestic market
Basaglar, a biosimilar product of Lantus(Insulin Glargine), a Sanofi’s basal insulin treatment, will enter the domestic diabetic treatment market.
Lilly Korea, as of the 25th, acquired approval of Basaglar Kwikpen an...
Listed pharmaceutical companies spend over KRW 300 billion into advertisement
It was observed listed pharmaceutical companies’ advertisement expenses up to the last September exceeded KRW 300 billion.
Moreover, Kwang Dong Pharmaceutical spend the most money, KRW 30 billion, in advertisement, a...
Pharmaceutical companies in KOSPI outnumbered ones in KOSPI in 3rd quarter
It was observed the average sales growth rate of KOSPI listed pharmaceutical companies, 6.1%, was higher than the one of KOSDAQ listed pharmaceutical companies by over 4%, and the average year-on-year sales growth rat...
Co-promotion of Yuhan with multinational companies contributes to API export expansionYuhan Corporation has recently made extraordinary moves. After the appointment of CEO Jung-hee Lee, the company has put investments worth of approximately KRW 45 billion in Bion...
|
Unconquerable fortress of Januvia substance patent defeats domestic pharmaceuticals
The wall of substance patent was sturdy. Like ‘Baraclude,’ ‘Januvia,’ a diabetic treatment, succeeded in defending its substance patent from other challenges. The nullity request against the extension of the term of t...
What is the relationship between Former President Young-sam Kim and the pharmacists society?
Young-sam Kim, the former president, died in the early morning of the 22nd while his relationship with the society of pharmacists has been brought up again.
Former President Kim was a politician belonging to an oppos...
Listed pharmaceutical companies own cashable assets of KRW 1.5694 trillion
Listed pharmaceutical companies have continuously increased the holding amount of cashable assets.
According to the Yakup Shinmoon’s analysis result of 3rd quarter’s reports of KOSPI and KOSDAQ listed pharmaceutical ...
Pharmaceutical association’s active discussion about Wage Peak System
In the employment and labor market where the youth unemployment and extension of retirement age have become controversy, while the adoption of the Wage Peak System is expected to be widely discussed, the domestic phar...
Hanmi Pharm announces a Chinese sales license agreement of new lung cancer treatment with ZAI LabOn the 23rd, Hanmi Pharm(CEO Kwan-soon Lee) announced an exclusive license agreement to handle the self-developed targeted lung cancer treatment(HM61713) across China(including ...
|
“Bubble in attracting foreign patients will pop soon”
Although the government is willing to maintain and expand the Korean healthcare wave by preparing a window of general support on foreign patients and pushing forward with the medical institution selection system, a co...
